Market Value275,545,000
Total Holdings40
File Date2020-04-09
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TGTX / TG Therapeutics, Inc.
INSM / Insmed Incorporated
YMTX / Yumanity Therapeutics Inc
KALV / KalVista Pharmaceuticals, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
DRNA / Dicerna Pharmaceuticals Inc
ZGNX / Zogenix Inc
FXF / Invesco CurrencyShares Swiss Franc Trust
AVDL / Avadel Pharmaceuticals plc
RCKT / Rocket Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
ECYT / Endocyte, Inc.
PTCT / PTC Therapeutics, Inc.
GRTS / Gritstone bio, Inc.
/ Immunomedics, Inc.
/ Immunomedics, Inc. Put
OBSV / ObsEva SA.
TSRO / TESARO, Inc.
BOLD / Boundless Bio, Inc.
ANAB / AnaptysBio, Inc.
BDSI / Biodelivery Sciences International
MOTS / Motus GI Holdings, Inc.
US64052L1061 / Neos Therapeutics, Inc.
SPPI / Spectrum Pharmaceuticals, Inc.
RDUS / Radius Recycling, Inc.
TVTX / Travere Therapeutics, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
NLTX / Neoleukin Therapeutics, Inc.
UROV / Urovant Sciences Ltd
TCDA / Tricida Inc
ASMB / Assembly Biosciences, Inc.
GNCA / Genocea Biosciences Inc
GBT / Global Blood Therapeutics Inc.
VRTX / Vertex Pharmaceuticals Incorporated
0PP / Portola Pharmaceuticals Inc
MRTX / Mirati Therapeutics, Inc. Put
PDSB / PDS Biotechnology Corporation
CBIO / Crescent Biopharma, Inc.
GLYC / GlycoMimetics, Inc.
GBT / Global Blood Therapeutics Inc. Call
GBT / Global Blood Therapeutics Inc. Put
ACAD / ACADIA Pharmaceuticals Inc. Call
KURA / Kura Oncology, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
ALLK / Allakos Inc.
SAGE / Sage Therapeutics, Inc. Call
SAGE / Sage Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
BHVN / Biohaven Ltd.
VRAY / ViewRay Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
BLUE / bluebird bio, Inc.
ITCI / Intra-Cellular Therapies, Inc. Call
APLS / Apellis Pharmaceuticals, Inc.
FOLD / Amicus Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Call
MDGL / Madrigal Pharmaceuticals, Inc.
ARVN / Arvinas, Inc.
LRMR / Larimar Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
ACAD / ACADIA Pharmaceuticals Inc.
SRPT / Sarepta Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.